| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6156277 | American Journal of Kidney Diseases | 2016 | 13 Pages |
Abstract
In this phase 2 study of anemia therapy in patients with end-stage renal disease on maintenance hemodialysis therapy, roxadustat was well tolerated and effectively maintained Hb levels.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Robert MD, Anatole MD, Steven MD, Sohan MD, Steven MD, Peter MD, Lona MD, Khalil G. PhD, Exec MBA, Gopal MBBS, Stefan PhD, RAC, Lynda MD, MSCE, K.H. Peony MD, Thomas B. MD (hc),